STE
STERIS plc
NYSE: STE · HEALTHCARE · MEDICAL DEVICES
$201.85
+0.05% today
Updated 2026-06-05
Market cap
$20.23B
P/E ratio
26.17
P/S ratio
3.41x
EPS (TTM)
$7.93
Dividend yield
1.19%
52W range
$195 – $268
Volume
0.7M
WallStSmart proprietary scores
70
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+7.8
Quality
B+6.5
Profitability
B4.7
Valuation
C7/9
Piotroski F-Score
Strong
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$275.20
+36.34%
12-Month target
$215.36
+6.69%
Intrinsic (DCF)
$159.97
Margin of safety
-52.20%
3 Strong Buy3 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Piotroski 7/9 — strong financial health
+ Free cash flow $245.20M — positive
+ Debt/equity 0.29x — low leverage
Risks
- 52.20% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM | 2027 (E) |
|---|---|---|---|---|---|---|
| Revenue | $4.54B | $5.14B | $5.46B | $5.94B | $5.94B | $6.4B |
| Net income | $107.03M | $378.24M | $614.64M | $785.10M | $220.30M | — |
| EPS | — | — | — | — | $7.93 | $11.21 |
| Free cash flow | $394.98M | $612.95M | $778.00M | $972.40M | $245.20M | — |
| Profit margin | 2.36% | 7.36% | 11.26% | 13.23% | 13.20% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-05 | CARESTIO, DANIEL A | Sale | 1,374 | $212.00 |
| 2026-06-04 | ZANGERLE, JOHN ADAM | Sale | 401 | $212.24 |
| 2026-06-04 | TAMARO, RENATO | Sale | 65 | $212.24 |
Peer comparison
Smart narrative
STERIS plc trades at $201.85. representing a P/E of 26.17x trailing earnings. Our Smart Value Score of 70/100 indicates the stock is good. The company scores 7/9 on the Piotroski F-Score. TTM revenue stands at $5.94B. with profit margins at 13.20%. Our DCF model estimates intrinsic value at $159.97.
Frequently asked questions
What is STERIS plc's stock price?
STERIS plc (STE) trades at $201.85, on a P/E of 26.2x and a P/S of 3.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is STERIS plc overvalued?
STERIS plc carries a Smart Value Score of 70/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $159.97 against the $201.85 price, so on cash flow terms the market is paying a premium for STERIS plc's growth. The Buy rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of STERIS plc (STE)?
The 12-month analyst consensus target is $275.20, about 36.3% above the current $201.85. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of STE by 2030?
Our research-backed model puts the 2030 base case at $967.87, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of STERIS plc (STE)?
Our DCF model estimates intrinsic value at $159.97, a -52.2% margin of safety versus today's $201.85. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is STERIS plc's revenue?
STERIS plc's trailing twelve-month revenue is $5.94B, and our model projects it reaching about $7.88B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio3.41x
ROE10.89%
Beta0.92
50D MA$215.95
200D MA$239.71
Shares out0.10B
Float0.10B
Short ratio—
Avg volume0.7M
Performance
1 week+0.00%
1 month+0.11%
3 months-3.06%
YTD-16.24%
1 year—
3 years—
5 years—